| Line item | 2026-03-31 FY | 2025-03-31 FY | 2024-03-31 FY | 2023-03-31 FY | 2022-03-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | $2.63B | $3.20B | $2.99B | $3.08B | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | – | – | – | – | – |
| SG&A | $398.00M | $344.60M | $349.20M | $387.00M | – | – |
| Operating Income | $97.10M | $124.60M | $139.70M | $139.60M | – | – |
| Interest Expense | $259.70M | $242.50M | $222.50M | $162.60M | – | – |
| Tax Expense | $16.20M | $14.50M | $34.20M | $14.30M | – | – |
| Net Income | -$198.30M | -$362.00M | -$1.10B | -$2.01B | -$188.20M | -$18.90M |
| EPS (basic) | -0.7000 | -0.4300 | -0.4200 | 0.0000 | – | – |
| EPS (diluted) | -0.7000 | -0.4300 | -0.4200 | 0.0000 | – | – |
| Shares (diluted) | $285.40M | $284.60M | $253.40M | $253.40M | – | – |